Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,204,797 | 2,254,797 | +50,000 | $44.65M | $81.96M | 8.53% | +$37.31M |
| Evolus, Inc.(EOLS) | 3,097,399 | 4,147,399 | +1,050,000 | $32.62M | $58.06M | 6.05% | +$25.45M |
| Kalvista Pharmaceuticals Inc | 3,440,345 | 4,125,345 | +685,000 | $42.14M | $48.93M | 5.09% | +$6.78M |
| Anaptysbio Inc | 1,950,609 | 1,330,879 | -619,730 | $41.78M | $29.97M | 3.12% | -$11.81M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,137,107 | 1,187,107 | +50,000 | $33.57M | $29.82M | 3.10% | -$3.75M |
| Altimmune, Inc.(ALT) | 2,750,000 | 2,750,000 | 0 | $30.94M | $28.00M | 2.91% | -$2.94M |
| Immunocore Holdings plcADS(IMCR) | 405,600 | 405,600 | 0 | $27.71M | $26.36M | 2.74% | -$1.35M |
| Inhibrx Inc | 0 | 700,000 | +700,000 | $0 | $24.47M | 2.55% | +$24.47M |
| Eli Lilly and Company(LLY) | 30,000 | 27,000 | -3,000 | $17.49M | $21.00M | 2.19% | +$3.52M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 300,000 | 0 | $18.84M | $20.49M | 2.13% | +$1.65M |
| PTC Therapeutics, Inc.(PTCT) | 900,000 | 700,000 | -200,000 | $24.80M | $20.36M | 2.12% | -$4.44M |
| Outlook Therapeutics, Inc.(OTLK) | 0 | 1,619,412 | +1,619,412 | $0 | $19.34M | 2.01% | +$19.34M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 250,000 | 660,000 | +410,000 | $7.49M | $17.78M | 1.85% | +$10.29M |
| Immunome, Inc.(IMNM) | 0 | 720,000 | +720,000 | $0 | $17.77M | 1.85% | +$17.77M |
| Avadel Pharmaceuticals PlcADR | 1,079,528 | 1,047,275 | -32,253 | $15.24M | $17.69M | 1.84% | +$2.45M |
| Ventyx Biosciences Inc | 2,000,000 | 3,100,000 | +1,100,000 | $4.94M | $17.05M | 1.78% | +$12.11M |
| Atea Pharmaceuticals, Inc.(AVIR) | 4,076,741 | 4,076,741 | 0 | $12.43M | $16.47M | 1.71% | +$4.04M |
| Elevation Oncology Inc | 3,667,600 | 3,060,000 | -607,600 | $1.97M | $15.70M | 1.63% | +$13.73M |
| Applied Therapeutics Inc | 0 | 2,230,000 | +2,230,000 | $0 | $15.16M | 1.58% | +$15.16M |
| Adicet Bio Inc | 876,352 | 6,407,400 | +5,531,048 | $1.66M | $15.06M | 1.57% | +$13.40M |
| Morphosys AgADS | 0 | 800,705 | +800,705 | $0 | $14.52M | 1.51% | +$14.52M |
| CytomX Therapeutics, Inc.(CTMX) | 6,550,000 | 6,450,000 | -100,000 | $10.15M | $14.06M | 1.46% | +$3.91M |
| Nuvation Bio Inc.CL A(NUVB) | 3,500,000 | 3,551,864 | +51,864 | $5.29M | $12.93M | 1.35% | +$7.64M |
| GSK plcADR(GSK) | 300,000 | 300,000 | 0 | $11.12M | $12.86M | 1.34% | +$1.74M |
| LENZ Therapeutics, Inc.(LENZ) | 0 | 547,616 | +547,616 | $0 | $12.23M | 1.27% | +$12.23M |
| Viridian Therapeutics, Inc.(VRDN) | 692,925 | 692,925 | 0 | $15.09M | $12.13M | 1.26% | -$2.96M |
| Zymeworks Inc.(ZYME) | 1,100,000 | 1,100,000 | 0 | $11.43M | $11.57M | 1.20% | +$143.0K |
| Cargo Therapeutics Inc | 160,544 | 466,809 | +306,265 | $3.72M | $10.42M | 1.08% | +$6.70M |
| Intra-Cellular Therapies Inc | 220,000 | 150,000 | -70,000 | $15.76M | $10.38M | 1.08% | -$5.38M |
| ANI Pharmaceuticals, Inc.(ANIP) | 0 | 150,000 | +150,000 | $0 | $10.37M | 1.08% | +$10.37M |
| Aurinia Pharmaceuticals Inc.(AUPH) | 550,000 | 2,050,000 | +1,500,000 | $4.94M | $10.27M | 1.07% | +$5.33M |
| AstraZeneca PLCADR(AZN) | 170,000 | 150,000 | -20,000 | $11.45M | $10.16M | 1.06% | -$1.29M |
| Kiniksa Pharmaceuticals LtdCL A | 600,000 | 500,000 | -100,000 | $10.52M | $9.87M | 1.03% | -$659.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 771,138 | 571,138 | -200,000 | $7.86M | $9.73M | 1.01% | +$1.87M |
| Acadia Pharmaceuticals Inc | 114,400 | 518,900 | +404,500 | $3.58M | $9.59M | 1.00% | +$6.01M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 271,200 | 281,200 | +10,000 | $8.76M | $9.44M | 0.98% | +$682.9K |
| Deciphera Pharmaceuticals In | 0 | 600,000 | +600,000 | $0 | $9.44M | 0.98% | +$9.44M |
| NVIDIA Corporation(NVDA) | 0 | 10,000 | +10,000 | $0 | $9.04M | 0.94% | +$9.04M |
| Viking Therapeutics, Inc.(VKTX) | 0 | 100,000 | +100,000 | $0 | $8.20M | 0.85% | +$8.20M |
| Black Diamond Therapeutics I | 1,803,200 | 1,603,200 | -200,000 | $5.07M | $8.13M | 0.85% | +$3.06M |
| Precision BioSciences, Inc.(DTIL) | 0 | 589,569 | +589,569 | $0 | $7.99M | 0.83% | +$7.99M |
| Dianthus Therapeutics, Inc.(DNTH) | 504,242 | 264,692 | -239,550 | $5.24M | $7.94M | 0.83% | +$2.70M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 215,000 | 116,500 | -98,500 | $13.46M | $7.94M | 0.83% | -$5.52M |
| Biohaven Ltd.(BHVN) | 140,000 | 140,000 | 0 | $5.99M | $7.66M | 0.80% | +$1.66M |
| Arvinas, Inc.(ARVN) | 80,000 | 180,000 | +100,000 | $3.29M | $7.43M | 0.77% | +$4.14M |
| Iovance Biotherapeutics, Inc.(IOVA) | 1,000,000 | 500,000 | -500,000 | $8.13M | $7.41M | 0.77% | -$720.0K |
| Vanda Pharmaceuticals Inc.(VNDA) | 248,190 | 1,751,654 | +1,503,464 | $1.05M | $7.20M | 0.75% | +$6.15M |
| Cytokinetics, Incorporated(CYTK) | 110,000 | 100,000 | -10,000 | $9.18M | $7.01M | 0.73% | -$2.17M |
| Apogee Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $6.64M | 0.69% | +$6.64M |
| Ionis Pharmaceuticals, Inc.(IONS) | 200,000 | 150,000 | -50,000 | $10.12M | $6.50M | 0.68% | -$3.62M |
| Verastem, Inc.(VSTM) | 741,514 | 541,514 | -200,000 | $6.04M | $6.39M | 0.67% | +$353.9K |
| Design Therapeutics, Inc.(DSGN) | 1,480,675 | 1,480,975 | +300 | $3.92M | $5.97M | 0.62% | +$2.04M |
| Nkarta, Inc.(NKTX) | 550,000 | 550,000 | 0 | $3.63M | $5.95M | 0.62% | +$2.32M |
| BeOne Medicines AGADR(ONC) | 85,000 | 37,000 | -48,000 | $15.33M | $5.79M | 0.60% | -$9.54M |
| Intellia Therapeutics, Inc.(NTLA) | 200,000 | 200,000 | 0 | $6.10M | $5.50M | 0.57% | -$596.0K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 300,000 | 300,000 | 0 | $2.82M | $5.24M | 0.55% | +$2.42M |
| Fate Therapeutics, Inc.(FATE) | 700,000 | 700,000 | 0 | $2.62M | $5.14M | 0.53% | +$2.52M |
| Heron Therapeutics, Inc.(HRTX) | 1,850,000 | 1,850,000 | 0 | $3.15M | $5.12M | 0.53% | +$1.98M |
| BioAtla, Inc.(BCAB) | 2,524,076 | 1,474,076 | -1,050,000 | $6.21M | $5.07M | 0.53% | -$1.14M |
| Reneo Pharmaceuticals Inc | 3,330,000 | 2,997,000 | -333,000 | $5.33M | $4.98M | 0.52% | -$353.0K |
| Meta Platforms, Inc.CL A(META) | 0 | 10,000 | +10,000 | $0 | $4.86M | 0.51% | +$4.86M |
| Bolt Biotherapeutics Inc | 3,652,244 | 3,420,000 | -232,244 | $4.09M | $4.79M | 0.50% | +$697.5K |
| Structure Therapeutics IncADS | 0 | 100,000 | +100,000 | $0 | $4.29M | 0.45% | +$4.29M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 800,000 | 800,000 | 0 | $4.79M | $4.06M | 0.42% | -$728.0K |
| Century Therapeutics, Inc.(IPSC) | 1,066,440 | 900,000 | -166,440 | $3.54M | $3.76M | 0.39% | +$221.4K |
| Bluebird Bio Inc | 1,700,000 | 2,500,000 | +800,000 | $2.35M | $3.20M | 0.33% | +$854.0K |
| IRulya Therapeutics Inc.(IRLA) | 3,220,000 | 2,947,652 | -272,348 | $3.38M | $3.12M | 0.33% | -$256.5K |
| Equity ComwlthCOM SH BEN INT | 300,000 | 165,261 | -134,739 | $5.76M | $3.12M | 0.32% | -$2.64M |
| Lantheus Holdings, Inc.(LNTH) | 0 | 50,000 | +50,000 | $0 | $3.11M | 0.32% | +$3.11M |
| Genmab A/SADS(GMAB) | 0 | 100,000 | +100,000 | $0 | $2.99M | 0.31% | +$2.99M |
| Mind Medicine Mindmed Inc | 0 | 300,000 | +300,000 | $0 | $2.82M | 0.29% | +$2.82M |
| Kinnate Biopharma Inc | 2,601,647 | 977,626 | -1,624,021 | $6.17M | $2.60M | 0.27% | -$3.57M |
| Athira Pharma Inc | 1,152,715 | 852,715 | -300,000 | $2.80M | $2.34M | 0.24% | -$464.7K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 4,387,238 | 1,443,619 | -2,943,619 | $3.48M | $2.28M | 0.24% | -$1.20M |
| Amarin Corp PlcADR | 3,086,544 | 2,500,000 | -586,544 | $2.69M | $2.23M | 0.23% | -$458.3K |
| Liquidia Corporation(LQDA) | 0 | 150,000 | +150,000 | $0 | $2.21M | 0.23% | +$2.21M |
| Kura Oncology, Inc.(KURA) | 0 | 100,000 | +100,000 | $0 | $2.13M | 0.22% | +$2.13M |
| Passage Bio, Inc.(PASG) | 2,400,000 | 1,500,000 | -900,000 | $2.42M | $2.02M | 0.21% | -$399.0K |
| New York Cmnty Bancorp Inc | 1,606,600 | 606,600 | -1,000,000 | $16.44M | $1.95M | 0.20% | -$14.48M |
| Aligos Therapeutics Inc | 2,189,847 | 1,650,000 | -539,847 | $1.45M | $1.62M | 0.17% | +$162.9K |
| Enzo Biochem Inc | 1,700,000 | 1,260,013 | -439,987 | $2.36M | $1.60M | 0.17% | -$762.8K |
| TG Therapeutics, Inc.(TGTX) | 100,000 | 100,000 | 0 | $1.71M | $1.52M | 0.16% | -$187.0K |
| Atara Biotherapeutics Inc | 0 | 1,879,923 | +1,879,923 | $0 | $1.30M | 0.14% | +$1.30M |
| Seer, Inc.CL A(SEER) | 0 | 674,125 | +674,125 | $0 | $1.28M | 0.13% | +$1.28M |
| InflaRx N.V.(IFRX) | 1,873,753 | 769,065 | -1,104,688 | $3.05M | $1.18M | 0.12% | -$1.87M |
| Avrobio Inc | 0 | 852,802 | +852,802 | $0 | $1.09M | 0.11% | +$1.09M |
| Acumen Pharmaceuticals, Inc.(ABOS) | 246,895 | 246,895 | 0 | $948.1K | $999.9K | 0.10% | +$51.8K |
| Revance Therapeutics Inc | 0 | 200,000 | +200,000 | $0 | $984.0K | 0.10% | +$984.0K |
| Atyr Pharma Inc | 471,134 | 471,134 | 0 | $664.3K | $918.7K | 0.10% | +$254.4K |
| Seres Therapeutics, Inc.(MCRB) | 1,792,888 | 907,112 | -885,776 | $2.51M | $702.2K | 0.07% | -$1.81M |
| uniQure N.V.SHS(QURE) | 600,000 | 133,921 | -466,079 | $4.06M | $696.4K | 0.07% | -$3.37M |
| Eagle Pharmaceuticals Inc | 118,857 | 118,857 | 0 | $621.6K | $622.8K | 0.06% | +$1.2K |
| Kezar Life Sciences Inc | 306,665 | 688,943 | +382,278 | $290.5K | $621.2K | 0.06% | +$330.6K |
| Journey Medical Corporation(DERM) | 0 | 138,625 | +138,625 | $0 | $510.1K | 0.05% | +$510.1K |
| Molecular Partners AGADS(MOLN) | 100,000 | 100,000 | 0 | $418.0K | $420.0K | 0.04% | +$2.0K |
| Nextcure Inc | 467,922 | 144,520 | -323,402 | $533.4K | $322.3K | 0.03% | -$211.2K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 200,000 | 100,000 | -100,000 | $2.94M | $284.0K | 0.03% | -$2.66M |
| Erasca, Inc.(ERAS) | 150,000 | 100,000 | -50,000 | $319.5K | $206.0K | 0.02% | -$113.5K |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 382 | +382 | $0 | $1.8K | 0.00% | +$1.8K |
| 908 Devices Inc.(MASS) | 100,000 | 0 | -100,000 | $1.12M | $0 | — | -$1.12M |